Publication | Open Access
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
78
Citations
29
References
2023
Year
HuNb<sub>TROP2-HSA</sub>-MMAE has desirable affinity, internalization efficiency and antitumor activity. It holds significant promise as a potential therapeutic option for the treatment of TROP2-positive pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1